Therefore, our results demonstrated that the MALAT-1 score was strongly correlated with prostate cancer risk in the overall group as well as in the subgroup with PSA=4-10 ng/ml and may serve as a noninvasive biomarker for the detection of PCa in urine. Here, KLK3 is linked to posterior cortical atrophy.